Firstly, although CRP is an established marker in the management of infections [14], it is non-specific for viral infections [14], and the notion of a new and potentially more comprehensive biomarker, such as LCR, for risk stratifying COVID-19 patients is highly desirable. The gene discussed is CRP; the disease is COVID-19.